Related Experiment Video

Updated: Mar 30, 2026

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta
10:27

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta

Published on: December 5, 2019

9.5K

E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers

Kazuma Masumoto1, Masatoshi Kitagawa

  • 1Department of Oral and Maxillofacial Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu 431-3192, Japan. kazusan@hama-med.ac.jp.

Current Cancer Drug Targets
|November 13, 2015
PubMed

Insights

The ubiquitin-proteasome pathway regulates cell growth. Inhibiting specific E3 ligases, like Skp2 and Pirh2, shows promise for treating oral and head and neck cancers by stabilizing tumor suppressors.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • The ubiquitin-proteasome pathway is crucial for cellular processes, with E3 ligases playing key roles in protein degradation.
  • Dysregulation of E3 ligases contributes to cancer development by disrupting the balance between oncogenes and tumor suppressors.
  • In oral and head and neck cancers, the degradation of p27(Kip1) is linked to poor prognosis.

Purpose of the Study:

  • To explore the role of E3 ligases in oral and head and neck cancers.
  • To identify potential therapeutic targets within the ubiquitin-proteasome pathway for oral cancer treatment.

Main Methods:

  • Review of literature on E3 ligases involved in cancer, specifically focusing on those targeting p27(Kip1).
  • Analysis of the association between E3 ligase expression (Skp2, Pirh2) and patient prognosis in oral cancers.
  • Discussion of small molecule inhibitors targeting E3 ligases, including SCF(Skp2) and HECT-type E3 ligases.

Main Results:

  • Several E3 ligases, including SCF(Skp2), KPC complex, Pirh2, and CRL4(DDB2-Artemis), mediate p27(Kip1) degradation.
  • Overexpression of Skp2 and Pirh2 correlates with poor prognosis in oral cancers.
  • HECT-type E3 ligases (WWP family, Smurf1) are implicated in oral cancer development.

Conclusions:

  • Targeting E3 ligases involved in p27(Kip1) degradation offers a promising therapeutic strategy for oral cancer.
  • Chemical inhibitors against E3 ligases like SCF(Skp2) and HECT-type E3 ligases represent potential anti-oral cancer drugs.

More Related Videos

In Vitro Analysis of E3 Ubiquitin Ligase Function06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

6.2K
Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

3.3K

Related Concept Videos

Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K